
Microbiotica raises £36 million to advance into Phase II
Biopharma company Microbiotica has closed £36 million in Series C financing to support the advancement of its treatment for ulcerative colitis. The financing was led by British Business Bank, with participation from Tencent, IP Group, Cambridge Innovation Capital, Flerie Invest, and Seventure Partners. All existing Series B investors participated in… Read More








